|
|
|
|
|
by samatman
2307 days ago
|
|
Yes, this is an important comparison when there is adequate data. Which, we're not really starting from the null hypothesis at this point, but let's pretend that we are. Starting from no data, saying that there's no evidence that vaping is less harmful than cigarettes is no different from saying there's no evidence that vaping is less harmful than guavas. There's no evidence. That's where the sentence needs to stop. Then you get evidence, and we can have an informed conversation. |
|
However, in the face of having to form public health policy decisions in the time between right now and a decade+ down the road where real, long-term studies can be completed, we can only use and compare that available data. Though we should hew very close to specific facts and avoid words open to very wide interpretation like "safer". (it may be safer along a single vector, carcinogens, but much worse in others, so it's a misleading term) We would be more wise to stick to specific known evidence like:
--Nicotine levels are similar, so there is little or no difference in health issues related to nicotine ingestion, except in so far as evidence shows nicotine salts used in vaping may hit your system faster.
--There are fewer known carcinogens or lower levels of them in vaping, but the effects of novel chemicals are not known. Short term health benefits in switching to vaping have been observed but longer terms outcomes are completely unknown, and could be worse.
--Use Risk, as apposed to a more ambiguous "safety", and say that vaping is not a risk-free activity from a health perspective.
The above could probably still be better stated, but I think the point is clear enough. This is no different than any other scientific issue or area of research. You use available data to convey the current state of knowledge, possible implications, further areas of study, etc. And as more data arrives, you expand and revise. But we're not starting from zero data.
A primary issue in this topic is that it is front & center in the media. Media in general is not good at conveying technical nuances, and the well-funded marketing arms of tobacco (and now vaping) companies have every reason to help the media make incorrect leaps of logic and over generalizations, e.g, fewer carcinogens == safer.
Another consideration is individual context: I'm trying to get my 67 year old father to switch from smoking to vaping because available evidence shows he will very likely be able to breath more easily, reduce his risk for heart disease, and so on. But he's 67: Long term risk from unknown vaping effects are probably a non issue for him, while he's about 4 years away from COPD. And there's zero chance of getting him to quit while I'd peg my chances around 1 in 10 of getting him to vape instead. If it were a friend my own age, I would have a different message, such as "You may very well be trading some short-term health for long-term issues that are as bad, or worse. Or maybe not, but we don't know, so quitting is the proper response, not switching to vaping"